SCAI and CAIC Announce the Formation of the North American COVID-19 ST-Segment Elevation Myocardial Infarction Registry (NACMI)

April 3, 2020 — The Society for Cardiovascular Angiography and Interventions (SCAI) and the Canadian Association of Interventional Cardiology (CAIC) have announced the formation of the North American COVID-19 ST-Segment Elevation Myocardial Infarction Registry (NACMI).

The study will be chaired by Tim Henry, MD (SCAI) and Payam Dehghani, MD (CAIC). Any COVID-19 positive patients or persons under investigation (PUI) with ST-Segment Elevation or new-onset left bundle branch block with a clinical correlate of myocardial ischemia (chest pain, dyspnea, cardiac arrest, hemodynamic instability) will be in enrolled. The data will be compared to an age and gender-matched control population from the existing Midwest STEMI Consortium, which is a large (>15,000), prospective multi-center registry of consecutive STEMI patients. The NACMI registry has pending central IRB approval and will have an EKG and angiographic core lab.

Interested sites can designate a local principal investigator and contact either SCAI PI Tim Henry (Tim.Henry@thechristhospital.com), CAIC PI Payam Dehghani (pdehghani@me.com) or the data coordinating center (santiago.garcia@allina.com or ross.garberich@allina.com) to obtain participating site information.

We believe that this registry has the potential to provide critically important time-sensitive data to inform the management and treatment guidelines applicable to COVID-19 patients.

Source: SCAI COVID-19 Resources